Brandenburg; Gunda

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brandenburg; Gunda.The latest application filed is for "monoclonal antibodies against claudin-18 for treatment of cancer".

Company Profile

3.10.9

Brandenburg; Gunda - Mainz DE
Brandenburg; Gunda - Hamburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20200385448 - Sahin; Ugur ; et al.	2020-12-10
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 10,738,108 - Sahin , et al. A	2020-08-11
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 10,174,104 - Sahin , et al. J	2019-01-08
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20180127489 - Sahin; Ugur ; et al.	2018-05-10
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 9,751,934 - Sahin , et al. September 5, 2	2017-09-05
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 9,499,609 - Sahin , et al. November 22, 2	2016-11-22
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20160185860 - Sahin; Ugur ; et al.	2016-06-30
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 9,212,228 - Sahin , et al. December 15, 2	2015-12-15
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20150252103 - Sahin; Ugur ; et al.	2015-09-10
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20150252104 - Sahin; Ugur ; et al.	2015-09-10
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 8,425,902 - Sahin , et al. April 23, 2	2013-04-23
Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer App 20120195830 - Sahin; Ugur ; et al.	2012-08-02
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20120164160 - Sahin; Ugur ; et al.	2012-06-28
Monoclonal antibodies against claudin-18 for treatment of cancer Grant 8,168,427 - Sahin , et al. May 1, 2	2012-05-01
Monoclonal Antibodies Against Claudin-18 for Treatment of Cancer App 20100166779 - Sahin; Ugur ; et al.	2010-07-01
Monoclonal Antibodies Against Claudin-18 For Treatment Of Cancer App 20090169547 - Sahin; Ugur ; et al.	2009-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.